GCMAX
Price
$38.30
Change
-$0.17 (-0.44%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

GCMAX vs VMCPX

Header iconGCMAX vs VMCPX Comparison
Open Charts GCMAX vs VMCPXBanner chart's image
Goldman Sachs Mid Cap Value A
Price$38.30
Change-$0.17 (-0.44%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GCMAX vs VMCPX Comparison Chart
Loading...
VS
GCMAX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMAX is a Buy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. GCMAX (1.24B). VMCPX pays higher dividends than GCMAX: VMCPX (1.51) vs GCMAX (0.52). GCMAX was incepted earlier than VMCPX: GCMAX (27 years) vs VMCPX (14 years). GCMAX is a more actively managed with annual turnover of: 64.00 vs. VMCPX (13.00). GCMAX has a lower initial minimum investment than VMCPX: GCMAX (1000) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 25.17 vs. GCMAX (20.93). VMCPX return over 5 years is better than : 56.93 vs. GCMAX (17.42).
GCMAXVMCPXGCMAX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years14 years-
Gain YTD12.12512.59396%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B172B1%
Annual Yield % from dividends0.521.5134%
Returns for 1 year20.9325.1783%
Returns for 3 years-9.539.85-97%
Returns for 5 years17.4256.9331%
Returns for 10 years-15.51128.75-12%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals